Meaning of Drugs from the Perspective of Patients with Diabetes and Hypertension: A Case Study in Phitsanulok Province
Article Sidebar
Main Article Content
Abstract
Objective: To understand the meaning of drug therapy from the viewpoint of patients with diabetes and hypertension. Methods: Qualitative research was conducted through in-depth interviews. Key informants were chosen using a purposive sampling method from those diagnosed with diabetes and hypertension for at least one year and were prescribed a minimum of two drugs for use on a regular basis. The data were collected in Bang Krathum District and Mueang District, Phitsanulok Province, until saturation was reached, involving 31 key informants. The study was conducted from January 2022 to December 2022. Data were analyzed using thematic analysis. Results: The majority of key informants were female (74.19%), with a mean age of 66.16 ± 8.90 years, a mean illness duration of 9.42 ± 4.87 years, and a mean number of regularly used drugs of 5.13 ± 1.45. Most of key informants attributed the meanings of drugs based on their experiences, perceptions, and beliefs. Medication was primarily viewed as a means to control disease symptoms, relieve discomfort, and address bodily abnormalities. Additionally, the meaning of drugs was associated with perceived benefits, drug efficacy, and concerns about potential side effects. All of which significantly influenced their drug use behaviors such as changes of doses, mostly the reduction of the number of pills, changes in the timing of drug administration, or seeking alternative treatments. Conclusion: This study sheds light on the perspectives of individuals living with chronic illnesses regarding the meaning of drugs, which may differ from the perspectives of healthcare professionals. It underscores the importance for medical personnel to comprehend the patient's understanding of drugs and drug-related behaviors among those with chronic conditions. This understanding can be integrated into treatment plans collaboratively developed with the patients.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
ผลการวิจัยและความคิดเห็นที่ปรากฏในบทความถือเป็นความคิดเห็นและอยู่ในความรับผิดชอบของผู้นิพนธ์ มิใช่ความเห็นหรือความรับผิดชอบของกองบรรณาธิการ หรือคณะเภสัชศาสตร์ มหาวิทยาลัยสงขลานครินทร์ ทั้งนี้ไม่รวมความผิดพลาดอันเกิดจากการพิมพ์ บทความที่ได้รับการเผยแพร่โดยวารสารเภสัชกรรมไทยถือเป็นสิทธิ์ของวารสารฯ
References
Buszko K, Obońska K, Michalski P, Kosobucka A, Jurek A, Wawrzyniak M, et al. The Adherence Scale in Chronic Diseases (ASCD). The power of knowledge: the key to successful patient — health care provider cooperation. Med Res J 2016; 1: 37-42.
Mekonnen GB and Gelayee DA. Low medication knowledge and adherence to oral chronic medications among patients attending community pharmacies: a cross-sectional study in a low-income country. Biomed Res Int 2020; 2020: 4392058. doi: 10.1155/2020/4392058.
Clyne B, Cooper JA, Boland F, Hughes CM, Fahey T, Smith SM. Beliefs about prescribed medication among older patients with polypharmacy: a mixed methods study in primary care. Br J Gen Pract 2017; 67: e507-18.
Van der geest S and Whyte SR. The charm of medicines: Metaphors and metonyms. Med Anthropol Q 1989; 3: 345-67.
Sringernyuang L. Socio-cultural dimensions of drug use in the community: development of knowledge from theory and research. Health Systems Research Institute, Ministry of Public Health; 1999.
Jongwilaikasem K, Lerkiatbundit S. Development of the Medication Adherence Scale for Thais (MAST).
Thai Journal of Pharmacy Practice 2021; 13: 17-30.
Chuengsatiansup K, Sringernyuang L, Paonil W. Medication versus community: socio-cultural dimen- sions. Nonthaburi: Society and Health Institute; 2007.
Limdul P. Drug consumer protection in the community. Ang Thong: Ang Thong Provincial Public Health Office; 1991.
Chanthapasa K. Patient insight: reason of patient (did not) take medicines. Khon Kaen: Faculty of Pharmaceutical Sciences, Khon Kaen University; 2021.
Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurt sova K, Duncan BB, et al. IDF diabetes atlas: Global, regional and country level diabetes prevalence estimates for 2021 and projections for 2045. Diabe- tes Res Clin Pract 2022; 183: 109-19.
Kanchanapibulwong A, Kamwangsanga P, Kaewta S. Situation report on NCDs, diabetes, hypertension and related risk factors 2019. Nonthaburi: Graphic and Design; 2020.
Ruangphaisan M and Chanthapasa K. Reasons for medication non-adherence from the perspective of type 2 diabetic patients: A case study of Warit-Chaphum Hospital, Sakon Nakorn. Thai Journal of Pharmacy Practice 2020; 12: 481-93.
U-ingrai S. Perspective, illness beliefs and self-care behavior among type 2 diabetic patients with third stage chronic kidney disease; case study in sub-district health promoting hospital. Chiangrai Medical Journal 2020; 2: 104-15.
Horne R, Weinman J, Hankins M. The Beliefs About Medicines Questionnaire: The development and evaluation of a new method for assessing the cognitive representation of medication. Psychol Health 1999; 14: 1-24.
Murray MD, Morrow DG, Weiner M, Clark DO, Tu W, Deer MM, et al. A Conceptual framework to study medication adherence in older adults. Am J Geriatr Pharmacother 2004; 2: 36-43.
Horne R. Representations of medication and treat- ment: advances in theory and measurement. In: Petrie KJ, WeinmanJ, editors. Perceptions of health and ill-ness: current research and applications. London: Harwood Academic; 1997.
Woodham N, Taneepanichskul S, Somrongthong R. Medication adherence and associated factors among elderly hypertension patients with uncon- trolled blood pressure in rural area, Northeast Thailand. J Health Res 2018; 32: 449-58.
Desta M, Yibeltal D, Memiah P, Ayenew T, Mulugeta H, Gadefaw M, et al. Antihypertensive medications adherence and associated uncontrolled blood pressure among hypertensive patients in Ethiopia: Systematic review and meta-analysis. Int J Afr Nurs Sci 2022; 16: 100404.
Rubio JS, García-Delgado P, García-Delgado P, Mateus-Santos H, Martínez-Martínez F. Martínez-Martínez. Measurement of patients’ knowledge of their medication in community pharmacies in Portugal. Cien Saude Colet 2015; 20: 219-28.
Simonsen BO, Johansson I, Daehlin GK, Osvik LM, Farup PG. Medication knowledge, certainty, and risk of errors in health care: a cross-sectional study. BMC Health Serv Res 2011; 11: 175. doi: 10.1186/1472-6963-11-175.
Van Der Geest S. Pharmaceutical anthropology: Perspectives for research and application. In: Van Der Geest S, Whyte SR. The context of medicines in developing countries. Dordrecht: Springer; 1988.
Chantra C and Moungkan J. Cause of left over drugs in elderly patients with chronic disease at Ruamjai community health care Wangthong, Phitsanulok Province. The 11th Hatyai National and International Conference; July 17th, 2020; Hatyai University. Songkhla: 2020.
Choowattanapakorn T and Suriyawong S. The view of illness among older persons with diabetes mellitus. Thai Journal of Nursing 2011; 26: 96-107.
Paechaiyaphum N and Theeranut A. Illness percep- tion of diabetic nephropathy among patient with diabetes mellitus type 2. Journal of Nursing and Health Care 2020; 38: 23-31.
Leaungsomnapa Y, Promproh S, Leaungsomnapa S, Sourthao Y. Influence of beliefs about medication on high group of medication adherence in hyper tensive patients. Journal of Prapokklao Hospital Clinical Medical Education Center 2013; 30: 146-57.
Sriprasert D. Medical dominance and the doctor-patient relationship. Thammasat Journal 2018; 37: 78-95.
Wongprasertsuk C, Cheuphudee N, Sathansuk W, Hiranpattanakul C. Drug use behavior of chronic disease patients of the Bang Talad Tambon Health Promoting Hospital. Kuakarun Journal of Nursing 2022; 29: 103-17.
Rosenstock M. Historical origins of the health belief model. Health Education Monographs 1974; 2: 328-35.
Rungsawang S. Factors related to polypharmacy medication adherence among older persons with chronic illness. Journal of Nursing, Siam University 2014; 18: 6-23.
